Determination of candidate metabolite biomarkers associated with recurrence of HCV-related hepatocellular carcinoma

Oncotarget
Zhicheng LiuGuowang Xu

Abstract

Hepatitis C virus (HCV) infection is associated with a high risk of developing hepatocellular carcinoma (HCC) and HCC recurrence remains the primary threat to outcomes after curative therapy. In this study, we compared recurrent and non-recurrent HCC patients treated with radiofrequency ablation (RFA) in order to identify characteristic metabolic profile variations associated with HCC recurrence. Gas chromatography-mass spectrometry (GC-MS) -based metabolomic analyses were conducted on serum samples obtained before and after RFA therapy. Significant variations were observed in metabolites in the glycerolipid, tricarboxylic acid (TCA) cycle, fatty acid, and amino acid pathways between recurrent and non-recurrent patients. Observed differences in metabolites associated with recurrence did not coincide before and after treatment except for fatty acids. Based on the comparison of serum metabolomes between recurrent and non-recurrent patients, key discriminatory metabolites were defined by a random forest (RF) test. Two combinations of these metabolites before and after RFA treatment showed outstanding performance in predicting HCV-related HCC recurrence, they were further confirmed by an external validation set. Our study showed th...Continue Reading

References

Dec 12, 2003·Lancet·Josep M LlovetJordi Bruix
Aug 23, 2005·Cancer Letters·Denys N WheatleyElaine Campbell
Feb 29, 2008·Journal of Hepatology·Josep M Llovet, Jordi Bruix
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Oct 19, 2010·Archives of Toxicology·Mamas MamasRoyston Goodacre
Oct 21, 2010·Cancer Research·Vincent M AsiagoDaniel Raftery
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
Apr 27, 2011·Molecular & Cellular Proteomics : MCP·Tianlu ChenWei Jia
Aug 20, 2011·PloS One·Barbara RoeWilliam W Hall
Mar 1, 2010·Nutrients·Philip C Calder
Apr 28, 2012·Gastroenterology·Hashem B El-Serag
Nov 9, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pierre NahonLaurence Le Moyec
Jan 25, 2013·Nature Reviews. Cancer·Alla ArzumanyanMark A Feitelson
Apr 2, 2013·Metabolomics : Official Journal of the Metabolomic Society·Jianguo XiaDavid S Wishart
Feb 18, 2014·Gut·Jordi BruixVincenzo Mazzaferro
Mar 4, 2014·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Lina ZhouGuowang Xu
Mar 26, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Asem I FitianRoniel Cabrera
Jun 27, 2014·World Journal of Gastroenterology : WJG·Hui-Chun LiShih-Yen Lo
Sep 12, 2016·Analytical and Bioanalytical Chemistry·Zhicheng LiuGuowang Xu

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear magnetic resonance
NMR
PCA
acetylation
imaging techniques

Software Mentioned

Leco ChromaTOF
SIMCA
MultiExperiment Viewer ( Mev
SPSS

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.